Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.38
-0.09 (-1.06%)
Jun 10, 2026, 12:22 PM EDT - Market open
Ocular Therapeutix Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +150.60% | May 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $30 | Buy | Maintains | $30 | +258.00% | May 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $21 | Buy | Reiterates | $21 | +150.60% | May 6, 2026 |
| Needham | Needham | Buy Maintains $18 | Buy | Maintains | $18 | +114.80% | May 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $20 | Buy | Maintains | $20 | +138.66% | May 5, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $31 | Buy | Maintains | $31 | +269.93% | Apr 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $24 → $27 | Buy | Reiterates | $24 → $27 | +222.20% | Mar 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.